The Role of Botulinum Toxin A in Treatment of Temporomandibular Joint Disorders: A Review

Temporomandibular joint disorders (TMDs) usually present with symptoms and signs such as pain, mandibular movement, dysfunction, or joint sounds. Botulinum toxin type A (BTX-A) is a biologic toxin which inhibits skeletal muscle through hindering the production of acetylcholine in the nerve endings....

Full description

Bibliographic Details
Main Authors: Rana Ataran, Ayla Bahramian, Zahra Jamali, Vahid Pishahang, Homayoon Sadeghi Barzegani, Parvin Sarbakhsh, Javad Yazdani
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2017-09-01
Series:Journal of Dentistry
Subjects:
Online Access:http://dentjods.sums.ac.ir/index.php/JDSUMS/article/view/1478/1066
_version_ 1818208305838817280
author Rana Ataran
Ayla Bahramian
Zahra Jamali
Vahid Pishahang
Homayoon Sadeghi Barzegani
Parvin Sarbakhsh
Javad Yazdani
author_facet Rana Ataran
Ayla Bahramian
Zahra Jamali
Vahid Pishahang
Homayoon Sadeghi Barzegani
Parvin Sarbakhsh
Javad Yazdani
author_sort Rana Ataran
collection DOAJ
description Temporomandibular joint disorders (TMDs) usually present with symptoms and signs such as pain, mandibular movement, dysfunction, or joint sounds. Botulinum toxin type A (BTX-A) is a biologic toxin which inhibits skeletal muscle through hindering the production of acetylcholine in the nerve endings. This toxin is used for the treatment of hyperactivity of lateral pterygoid muscle and TMD symptoms. This comprehensive review aimed to evaluate the effect of BTX-A injections in the lateral pterygoid muscle on treatment of TMDs symptoms. In this study, online databases including Scopus, Medline, Ebsco, Cochrane, EMBASE, and Google scholar were searched for the keywords “pterygoid muscle” and “Onabotulinumtoxin A”. Twenty-four articles were eligible to be enrolled in the study. In 4 interventional studies and 20 descriptive studies, BTX-A was used for the treatment of TMDs. The dosage and number of injections were different in each study; however, the injection methods were relatively similar. Regardless of the type, number of injections, and dosage, injection of BTX-A in lateral pterygoid seems effective in reducing the click sound and other TMJ-related muscle disorders such as pain, hyperactivity, and dysfunction.
first_indexed 2024-12-12T04:42:43Z
format Article
id doaj.art-ea3409e9f69740a8bcf1565aeba8f177
institution Directory Open Access Journal
issn 2345-6485
2345-6418
language English
last_indexed 2024-12-12T04:42:43Z
publishDate 2017-09-01
publisher Shiraz University of Medical Sciences
record_format Article
series Journal of Dentistry
spelling doaj.art-ea3409e9f69740a8bcf1565aeba8f1772022-12-22T00:37:44ZengShiraz University of Medical SciencesJournal of Dentistry2345-64852345-64182017-09-01183157164The Role of Botulinum Toxin A in Treatment of Temporomandibular Joint Disorders: A ReviewRana Ataran 0Ayla Bahramian 1Zahra Jamali 2Vahid Pishahang 3Homayoon Sadeghi Barzegani 4Parvin Sarbakhsh5Javad Yazdani 6Dept. of Oral Medicine, School of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.Dept. of Oral Medicine, School of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.Dept. of Oral Medicine, School of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.Postgraduate Student, Dept. of Orthodontics, Islamic Azad University of Tehran, Tehran, Iran.Injury Epidemiology and Prevention Researcher, Dept. of Statistics and Epidemiology, Tabriz University of Medical Sciences, Tabriz, Iran.Dept. of Statistics and Epidemiology, Tabriz University of Medical Sciences, Tabriz, Iran.Dept. of Maxillofacial Surgery, Tabriz University of Medical Sciences, Tabriz, Iran.Temporomandibular joint disorders (TMDs) usually present with symptoms and signs such as pain, mandibular movement, dysfunction, or joint sounds. Botulinum toxin type A (BTX-A) is a biologic toxin which inhibits skeletal muscle through hindering the production of acetylcholine in the nerve endings. This toxin is used for the treatment of hyperactivity of lateral pterygoid muscle and TMD symptoms. This comprehensive review aimed to evaluate the effect of BTX-A injections in the lateral pterygoid muscle on treatment of TMDs symptoms. In this study, online databases including Scopus, Medline, Ebsco, Cochrane, EMBASE, and Google scholar were searched for the keywords “pterygoid muscle” and “Onabotulinumtoxin A”. Twenty-four articles were eligible to be enrolled in the study. In 4 interventional studies and 20 descriptive studies, BTX-A was used for the treatment of TMDs. The dosage and number of injections were different in each study; however, the injection methods were relatively similar. Regardless of the type, number of injections, and dosage, injection of BTX-A in lateral pterygoid seems effective in reducing the click sound and other TMJ-related muscle disorders such as pain, hyperactivity, and dysfunction.http://dentjods.sums.ac.ir/index.php/JDSUMS/article/view/1478/1066●Temporomandibular Joint ● Pterygoid Muscles ● Botulinum Toxin
spellingShingle Rana Ataran
Ayla Bahramian
Zahra Jamali
Vahid Pishahang
Homayoon Sadeghi Barzegani
Parvin Sarbakhsh
Javad Yazdani
The Role of Botulinum Toxin A in Treatment of Temporomandibular Joint Disorders: A Review
Journal of Dentistry
●Temporomandibular Joint ● Pterygoid Muscles ● Botulinum Toxin
title The Role of Botulinum Toxin A in Treatment of Temporomandibular Joint Disorders: A Review
title_full The Role of Botulinum Toxin A in Treatment of Temporomandibular Joint Disorders: A Review
title_fullStr The Role of Botulinum Toxin A in Treatment of Temporomandibular Joint Disorders: A Review
title_full_unstemmed The Role of Botulinum Toxin A in Treatment of Temporomandibular Joint Disorders: A Review
title_short The Role of Botulinum Toxin A in Treatment of Temporomandibular Joint Disorders: A Review
title_sort role of botulinum toxin a in treatment of temporomandibular joint disorders a review
topic ●Temporomandibular Joint ● Pterygoid Muscles ● Botulinum Toxin
url http://dentjods.sums.ac.ir/index.php/JDSUMS/article/view/1478/1066
work_keys_str_mv AT ranaataran theroleofbotulinumtoxinaintreatmentoftemporomandibularjointdisordersareview
AT aylabahramian theroleofbotulinumtoxinaintreatmentoftemporomandibularjointdisordersareview
AT zahrajamali theroleofbotulinumtoxinaintreatmentoftemporomandibularjointdisordersareview
AT vahidpishahang theroleofbotulinumtoxinaintreatmentoftemporomandibularjointdisordersareview
AT homayoonsadeghibarzegani theroleofbotulinumtoxinaintreatmentoftemporomandibularjointdisordersareview
AT parvinsarbakhsh theroleofbotulinumtoxinaintreatmentoftemporomandibularjointdisordersareview
AT javadyazdani theroleofbotulinumtoxinaintreatmentoftemporomandibularjointdisordersareview
AT ranaataran roleofbotulinumtoxinaintreatmentoftemporomandibularjointdisordersareview
AT aylabahramian roleofbotulinumtoxinaintreatmentoftemporomandibularjointdisordersareview
AT zahrajamali roleofbotulinumtoxinaintreatmentoftemporomandibularjointdisordersareview
AT vahidpishahang roleofbotulinumtoxinaintreatmentoftemporomandibularjointdisordersareview
AT homayoonsadeghibarzegani roleofbotulinumtoxinaintreatmentoftemporomandibularjointdisordersareview
AT parvinsarbakhsh roleofbotulinumtoxinaintreatmentoftemporomandibularjointdisordersareview
AT javadyazdani roleofbotulinumtoxinaintreatmentoftemporomandibularjointdisordersareview